GSK Announces Submission of Albiglutide Bla to the Us Fda for the Treatment of Type 2 Diabetes
GlaxoSmithKline plc today announced a regulatory submission to the US Food and Drug Administration for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes.
Join the discussion below, or Read more at Drugs.com.
#1 Jan 15, 2013
Learn more about Albiglutide at http://www.rxwiki.com/albiglutide
Add your comments below
|Bashful? Buy the little blue pill online (May '13)||Feb 21||ken||14|
|Berkshire buys Teva, feels IBM blues as Apple b...||Feb 15||follow the money||1|
|APS teams with First Solar on plant with batter...||Feb 14||Solarman||1|
|Gay couples find path to parenthood in Greenwich||Feb 13||Christsharian Law||16|
|John Rich, 56, championed town's dog park||Jan 30||America Gentleman...||1|
|Prom in the hospital: For one night, just kids (Apr '10)||Jan 29||FART FOLLOWERS||2|
|Tiny Colorado County sues giant opioid makers f...||Jan 29||marta||1|
Find what you want!
Search Healthcare Industry Forum Now
Copyright © 2018 Topix LLC